Ballentine Partners’s Astera Labs ALAB Stock Holding History

Ballentine Partners’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$236K	Buy	+489	New	+$130K	﹤0.01%	930

Other funds holding ALAB

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

SIC

Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SSA

Sierra Summit Advisors Incline Village, Nevada $895M AUM 106% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

PAS

Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return

TEC

Tensor Edge Capital Weston, Massachusetts $1.51B AUM

MLCM

M & L Capital Management London, United Kingdom $370M AUM 165.61% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Ballentine Partners's ALAB Position: Q2 2026 in Review

Ballentine Partners opened a new position in Astera Labs (ALAB) in Q2 2026: 489 shares worth $236K. The stake represents ﹤0.01% of the portfolio and ranks #930 among its holdings.

167 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Ballentine Partners held 489 shares of Astera Labs worth $236K as of Q2 2026.
Astera Labs was a new Ballentine Partners position in Q2 2026.
Astera Labs made up ﹤0.01% of Ballentine Partners's portfolio in Q2 2026, its #930 holding.
167 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.